Q1WB
EBS icon

Quest 10 Wealth Builders’s Emergent Biosolutions EBS Stock Holding History

Quest 10 Wealth Builders’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$855 Hold
102
– – ﹤0.01% 700
2026
Q1 		$847 Hold
102
– – ﹤0.01% 702
2025
Q4 		$1.26K Hold
102
– – ﹤0.01% 612
2025
Q3 		$900 Hold
102
– – ﹤0.01% 716
2025
Q2 		$651 Hold
102
– – ﹤0.01% 658
2025
Q1 		$496 Hold
102
– – ﹤0.01% 652
2024
Q4 		$975 Buy
+102
New +$936 ﹤0.01% 652

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Quest 10 Wealth Builders's EBS Position: Q2 2026 in Review

Quest 10 Wealth Builders held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 102 shares worth $855. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Quest 10 Wealth Builders first reported a position in EBS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.26K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Quest 10 Wealth Builders held 102 shares of Emergent Biosolutions worth $855 as of Q2 2026.
  • Quest 10 Wealth Builders left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #700 holding.
  • Quest 10 Wealth Builders first reported a position in Emergent Biosolutions in Q4 2024 and has held it in 7 quarters since.
  • Quest 10 Wealth Builders's Emergent Biosolutions position peaked at $1.26K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.